biote Corp. – NASDAQ:BTMDW

Financial Health
0
1
2
3
4
5
6
7
8
9

biote Corp. stock price quarterly change

+247.13%
quarter

biote Corp. key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 0.01
EV/Sales
 -0.27
EV/EBITDA
 -0.50
Price/Sales
 0.01
Price/Book
 -0.05
PEG ratio
 -0.01
EPS
 0.17
Revenue
 187.32M
EBITDA
 39.86M
Income
 8.05M
Revenue Q/Q
 4.37%
Revenue Y/Y
 8.49%
Profit margin
 50.86%
Oper. margin
 -56.78%
Gross margin
 68.06%
EBIT margin
 -56.78%
EBITDA margin
 21.28%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

biote Corp. stock price history

biote Corp. stock forecast

biote Corp. financial statements

Profit Margin

biote Corp. (NASDAQ:BTMDW): Profit margin
Jun 2023 49.25M -5.14M -10.44%
Sep 2023 45.55M 7.53M 16.53%
Dec 2023 45.70M 7.73M 16.92%
Mar 2024 46.80M -2.06M -4.42%
BTMDW income statement history
0%
Yield TTM
biote Corp. (NASDAQ:BTMDW): Payout ratio
Payout ratio 0%
biote Corp. (NASDAQ:BTMDW): Dividend Yield
2019 74.4%
2020 17.5%
2021 15.36%
2022 42.87%
2023 6.85%
BTMDW dividends history

Debt to Assets

biote Corp. (NASDAQ:BTMDW): Debt to assets
Jun 2023 139052000 212.29M 152.67%
Sep 2023 149749000 201.01M 134.23%
Dec 2023 155295000 191.84M 123.53%
Mar 2024 160108000 205.00M 128.04%
BTMDW balance sheet history

Cash Flow

biote Corp. (NASDAQ:BTMDW): Cash Flow
Jun 2023 6.77M -20.84M -5.05M
Sep 2023 160K -484K -2.56M
Dec 2023 6.95M 18.99M -2.52M
Mar 2024 7.37M -12.17M -5.40M
BTMDW cash flow history

biote Corp. other data

biote Corp.
Insider Trading

biote Corp. (NASDAQ:BTMDW): Insider trades (number of shares)
Period Buy Sel
Jan 2023 326350 1730768
Feb 2023 375000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ROYSTONE CAPITAL MANAGEMENT LP 10 percent owner
 Class A common stock, par value $0.0001 per share 375,000 $3.25 $1,218,750
Purchase
MORRIS DEBRA L director Class A Common Stock 30,000 $3 $90,000
Purchase
KAMDAR SAMAR JAGAT officer: Chief Financial Officer
 Class A Common Stock 13,000 $3 $39,000
Purchase
CONE STEPHEN MARK director
 Class A Common Stock 83,350 $3 $250,050
Purchase
HEYER ANDREW R director
 Class A Common Stock 100,000 $3 $300,000
Purchase
HEYER ANDREW R director
 Class A Common Stock 100,000 $3 $300,000
Sale
WEBER TERESA SUE director, officer: Chief Execut..
 Class A Common Stock 865,384 $3 $2,596,152
Sale
BEER MARC D director
 Class A Common Stock 865,384 $3 $2,596,152
Option
CONLON MARY ELIZABETH officer: General Counsel
 Phantom Stock 39,375 N/A N/A
Option
CONLON MARY ELIZABETH officer: General Counsel
 Class A Common Stock 39,375 N/A N/A
BTMDW insider trading transactions

Frequently Asked Questions (FAQ)

  • When is biote Corp.'s next earnings date?

    Unfortunately, biote Corp.'s (BTMDW) next earnings date is currently unknown.

  • Does biote Corp. pay dividends?

    No, biote Corp. does not pay dividends.

  • What is biote Corp.'s stock symbol?

    biote Corp. is traded on the NASDAQ under the ticker symbol "BTMDW".

  • What is biote Corp.'s primary industry?

    Company operates in the Healthcare sector and Medical Care Facilities industry.

  • How do i buy shares of biote Corp.?

    Shares of biote Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When biote Corp. went public?

    biote Corp. is publicly traded company for more then 3 years since IPO on 27 May 2022.

  • What is biote Corp.'s official website?

    The official website for biote Corp. is biote.com.

  • Where are biote Corp.'s headquarters?

    biote Corp. is headquartered at 501 Madison Avenue, New York, NY.

  • How can i contact biote Corp.?

    biote Corp.'s mailing address is 501 Madison Avenue, New York, NY and company can be reached via phone at +212 6169600.

biote Corp. company profile:

biote Corp.

biote.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Medical Care Facilities

Sector:

Healthcare

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

+212 6169600
501 Madison Avenue
New York, NY 75038

CIK: 0001819253
:
: